Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $49.25 million. The enterprise value is $55,909.

Market Cap	49.25M
Enterprise Value	55,909

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

JSPR has 27.98 million shares outstanding. The number of shares has increased by 15.70% in one year.

Current Share Class	27.98M
Shares Outstanding	27.98M
Shares Change (YoY)	+15.70%
Shares Change (QoQ)	+8.49%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	56.92%
Float	21.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.26
P/TBV Ratio	4.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.15.

Current Ratio	2.59
Quick Ratio	2.42
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -191.12% and return on invested capital (ROIC) is -115.53%.

Return on Equity (ROE)	-191.12%
Return on Assets (ROA)	-72.92%
Return on Invested Capital (ROIC)	-115.53%
Return on Capital Employed (ROCE)	-251.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.89% in the last 52 weeks. The beta is 3.06, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	3.06
52-Week Price Change	-91.89%
50-Day Moving Average	1.92
200-Day Moving Average	3.44
Relative Strength Index (RSI)	46.77
Average Volume (20 Days)	3,968,986

Short Selling Information

The latest short interest is 3.46 million, so 12.35% of the outstanding shares have been sold short.

Short Interest	3.46M
Short Previous Month	1.83M
Short % of Shares Out	12.35%
Short % of Float	15.92%
Short Ratio (days to cover)	0.90

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.52M
Pretax Income	-91.02M
Net Income	-91.02M
EBITDA	-90.51M
EBIT	-91.52M
Earnings Per Share (EPS)	-$5.79

Balance Sheet

The company has $50.90 million in cash and $1.70 million in debt, giving a net cash position of $49.20 million or $1.76 per share.

Cash & Cash Equivalents	50.90M
Total Debt	1.70M
Net Cash	49.20M
Net Cash Per Share	$1.76
Equity (Book Value)	11.57M
Book Value Per Share	0.41
Working Capital	33.52M

Cash Flow

In the last 12 months, operating cash flow was -$76.43 million and capital expenditures -$103,000, giving a free cash flow of -$76.53 million.

Operating Cash Flow	-76.43M
Capital Expenditures	-103,000
Free Cash Flow	-76.53M
FCF Per Share	-$2.73

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.70%
Shareholder Yield	n/a
Earnings Yield	-184.81%
FCF Yield	-155.39%

Analyst Forecast

The average price target for JSPR is $21.44, which is 1,118.18% higher than the current price. The consensus rating is "Buy".

Price Target	$21.44
Price Target Difference	1,118.18%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1